Prostatic Cancer, Castration-Resistant Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 2
A Study of JSB462 (Luxdegalutamide) Plus Lutetium (177Lu) Vipivotide Tetraxetan in Patients With Metastatic Castration Resistant Prostate Cancer (mCRPC)
Prostatic Cancer, Castration-Resistant
Novartis Pharmaceuticals130 enrolled51 locationsNCT07047118
Recruiting
Phase 3
Treatment With Darolutamide +/- Radiation Therapy for Patients With a Castration Resistant Cancer and Metastases Detected by Functional Imaging
Prostatic Cancer, Castration-Resistant
UNICANCER336 enrolled4 locationsNCT06276465